Table 3.
Mortality at 3 and 12 months and cardiovascular events in patients using aspirin + dipyridamole (A + D)vs.use of aspirin only (A) after acute stroke/TIA (%)
| 3-mo | 12-mo | 3-mo CVD | 12-mo CVD | |
|---|---|---|---|---|
| Aspirin + Dipyridamole |
1.1 |
5.7** |
5.7 |
14.7 |
| (n = 275) |
|
|
|
|
| Aspirin only |
5.7 |
10.7 |
3.8 |
10.9 |
| (n = 262) |
** = P < 0.01 for comparison A + D vs.A only, : mortality, CVD: Cardiovascular Disease (recurring stroke/TIA, non-fatal myocardial infarction, congestive heart failure, ischemic heart disease), 3-mo: 3-months mortality; 12-mo: 12-months mortality. Results are presented in percent(%).